Krystal Biotech, Inc. - 8-K Filing
Krystal Biotech held its annual stockholder meeting on May 15, 2026, where four proposals were voted upon. Stockholders elected directors Krish S. Krishnan and Christopher Mason to the board; ratified KPMG LLP as their independent auditor with 94% of votes in favor; approved executive compensation for FY2025; and unaffiliated stockholders approved the Non-Employee Director Compensation Policy. (Items: 5.07 Submission of Matters to a Vote of Security HoldersOn May 15, 2026, Krystal Biotech, Inc)
Tickers: $KRYS